EVER Neuro Pharma GmbH, Austria - search results

Ireland - English - HPRA (Health Products Regulatory Authority)

dacepton 10 mg/ml solution for inj/inf

ever neuro pharma gmbh - apomorphine hydrochloride hemihydrate - solution for inj/inf - 10 mg/ml - dopamine agonists

European Union - English - EMA (European Medicines Agency)

clopidogrel acino pharma gmbh

acino pharma gmbh - clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.for further information please refer to section 5.1.

European Union - English - EMA (European Medicines Agency)

rivastigmine 1 a pharma

1 a pharma gmbh - rivastigmine - alzheimer disease; dementia; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

ever pharma - basic insulin pen, replaceable-cartridge

interpharma pty ltd - 45771 - cartridge-accepting autoinjector, mechanical - the intended use of the apomine d-mine pen is to deliver apomorphine subcutaneously in patients with parkinsons's disease on a daily basis. the intermittent administration via pen application allows the rescue therapy with stimulation of striatal dopamine receptors which matches the physiological situation of the striatum in the brain.